Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INSULIN DELIVERY SYSTEM INDUSTRY
2.1 Summary about Insulin Delivery System Industry
2.2 Insulin Delivery System Market Trends
2.2.1 Insulin Delivery System Production & Consumption Trends
2.2.2 Insulin Delivery System Demand Structure Trends
2.3 Insulin Delivery System Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Insulin Syringes
4.2.2 Insulin PumpS
4.2.3 Insulin Pens
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Specialty Diabetic Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Insulin Syringes
5.2.2 Insulin PumpS
5.2.3 Insulin Pens
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Specialty Diabetic Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Insulin Syringes
6.2.2 Insulin PumpS
6.2.3 Insulin Pens
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Specialty Diabetic Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Insulin Syringes
7.2.2 Insulin PumpS
7.2.3 Insulin Pens
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Specialty Diabetic Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Insulin Syringes
8.2.2 Insulin PumpS
8.2.3 Insulin Pens
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Specialty Diabetic Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Insulin Syringes
9.2.2 Insulin PumpS
9.2.3 Insulin Pens
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Specialty Diabetic Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 BD
10.1.2 Novo Nordisk
10.1.3 Sanofi
10.1.4 Eli Lilly
10.1.5 Medtronic
10.1.6 Animas
10.1.7 Beta Bionics
10.1.8 Cellnovo
10.1.9 Copernicus
10.1.10 Dance Biopharm
10.1.11 Debiotech
10.1.12 InsuJet
10.1.13 Insulet
10.1.14 MannKind
10.1.15 Owen Mumford
10.1.16 Roche
10.1.17 SHL
10.1.18 SOOIL
10.1.19 Tandem Diabetes Care
10.1.20 Valeritas
10.1.21 West Pharma
10.1.22 Ypsomed
10.2 Insulin Delivery System Sales Date of Major Players (2017-2020e)
10.2.1 BD
10.2.2 Novo Nordisk
10.2.3 Sanofi
10.2.4 Eli Lilly
10.2.5 Medtronic
10.2.6 Animas
10.2.7 Beta Bionics
10.2.8 Cellnovo
10.2.9 Copernicus
10.2.10 Dance Biopharm
10.2.11 Debiotech
10.2.12 InsuJet
10.2.13 Insulet
10.2.14 MannKind
10.2.15 Owen Mumford
10.2.16 Roche
10.2.17 SHL
10.2.18 SOOIL
10.2.19 Tandem Diabetes Care
10.2.20 Valeritas
10.2.21 West Pharma
10.2.22 Ypsomed
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Insulin Delivery System Product Type Overview
Table Insulin Delivery System Product Type Market Share List
Table Insulin Delivery System Product Type of Major Players
Table Brief Introduction of BD
Table Brief Introduction of Novo Nordisk
Table Brief Introduction of Sanofi
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Medtronic
Table Brief Introduction of Animas
Table Brief Introduction of Beta Bionics
Table Brief Introduction of Cellnovo
Table Brief Introduction of Copernicus
Table Brief Introduction of Dance Biopharm
Table Brief Introduction of Debiotech
Table Brief Introduction of InsuJet
Table Brief Introduction of Insulet
Table Brief Introduction of MannKind
Table Brief Introduction of Owen Mumford
Table Brief Introduction of Roche
Table Brief Introduction of SHL
Table Brief Introduction of SOOIL
Table Brief Introduction of Tandem Diabetes Care
Table Brief Introduction of Valeritas
Table Brief Introduction of West Pharma
Table Brief Introduction of Ypsomed
Table Products & Services of BD
Table Products & Services of Novo Nordisk
Table Products & Services of Sanofi
Table Products & Services of Eli Lilly
Table Products & Services of Medtronic
Table Products & Services of Animas
Table Products & Services of Beta Bionics
Table Products & Services of Cellnovo
Table Products & Services of Copernicus
Table Products & Services of Dance Biopharm
Table Products & Services of Debiotech
Table Products & Services of InsuJet
Table Products & Services of Insulet
Table Products & Services of MannKind
Table Products & Services of Owen Mumford
Table Products & Services of Roche
Table Products & Services of SHL
Table Products & Services of SOOIL
Table Products & Services of Tandem Diabetes Care
Table Products & Services of Valeritas
Table Products & Services of West Pharma
Table Products & Services of Ypsomed
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Insulin Delivery System Market Forecast (Million USD) by Region 2021f-2026f
Table Global Insulin Delivery System Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Insulin Delivery System Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Insulin Delivery System Market Forecast (Million USD) Share by Demand 2021f-2026f